Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422136 · ClinicalTrials.gov registry record
Genetics of Middle Ear Disease
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 2,121
- Enrollment target
NCT00422136: Completed study, sponsored by University of Pittsburgh.
NCT00422136 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00422136 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 2,121 participants
- Enrollment target
Study Summary
The goal of this study is to identify the genes that contribute to susceptibility to recurrent/persistent middle ear disease. Five hundred families with at least 2 children who have undergone tympanostomy tube insertion will be enrolled. A blood sample will be obtained from the children who had tubes and any available parent (at least 1), as well as any siblings without significant histories of middle ear disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,121 participants |
| Start Date | 2002-07 |
| Est. Completion | 2009-07 |
What the finished NCT00422136 record still lists
NCT00422136 is an observational study that tracks outcomes without assigning an intervention. Its 2,121 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00422136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00422136 about?
NCT00422136 is a clinical study titled "Genetics of Middle Ear Disease". The goal of this study is to identify the genes that contribute to susceptibility to recurrent/persistent middle ear disease. Five hundred families with at least 2 children who have undergone tympanostomy tube insertion will be enrolled. A blood sample will be obtained from the children who had tube...
What is the current status of trial NCT00422136?
This trial is currently completed. The enrollment target is 2,121 participants. The study started on 2002-07. Estimated completion is 2009-07.
Who is sponsoring clinical trial NCT00422136?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia